Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2009 Nov 10;123(1):59–71. doi: 10.1007/s10549-009-0617-5

Table 2.

Cox proportional hazard models for ERα-negative and ERα-positive cancers

Predictor Hazard ratio (95% CIa) P-value
ERα-negative cancers
 Gli1-positive (nuclear) 6.89 (1.97, 24.14) 0.0026
 ErbB2 immunoscore 1.89 (1.04, 3.44) 0.0376
 Clinical stage (I, II, III, IV) 4.12 (1.22, 13.98) 0.0230
ERα-positive cancers
 Gli1-positive (nuclear) 1.62 (0.66, 4.00) 0.2952
 ErbB2 immunoscore 0.66 (0.33, 1.34) 0.2543
 Clinical stage (I, II, III, IV) 2.26 (1.25, 4.09) 0.0069
a

Confidence interval